You are here: Industry Insights > R&D

News List

3M Drug Delivery Systems Relocates UK R&D contractpharma
April 02, 2019
New R&D site covers more than 1,300 square meters of specifically-configured laboratory space for the development of inhalation therapies
Merck & Co pens $340m pain drug deal with KCL and Wellcome pharmaphorum
March 12, 2019
Merck & Co has announced a deal with King’s College London (KCL) and Wellcome to investigate a new class of painkillers that could provide an alternative to opioids and their dangerous side-effects.
NHS Long Term Plan: focus on R&D and digital innovation pharmaceutical-technology
January 08, 2019
NHS Long Term Plan to build upon the successes of the health service to data and create a ‘new service model for the 21st century’.
Deloitte finds Pharma returns on R&D reach new low europeanpharmaceuticalreview
January 04, 2019
Deloitte has found a sharp decline in the returns on investment from top pharmaceutical companies, with returns at almost half of what they were in 2010
R&D returns fall to lowest level in nine years: Deloitte, GlobalData biospectrumasia
December 26, 2018
‘Unlocking R&D productivity: Measuring the return from pharmaceutical innovation 2018’ published by Deloitte, reveals that returns are down 1.8 percentage points from 3.7 per cent in 2017, and forecast average peak sale.
Can China’s R&D sector shake its reputational issues in 2019? fiercebiotech
December 26, 2018
While 2018 was a big year for Chinese R&D on the whole, the sector hit the headlines for the wrong reasons.
Most pharma firms doing little R&D for poorer patients pharmaphorum
December 17, 2018
A ranking of pharma companies developing new medicines for low- and middle-income countries has revealed that just five companies are responsible for almost two-thirds of projects.....
Most pharma firms doing little R&D for poorer patients pharmaphorum
November 27, 2018
A ranking of pharma companies developing new medicines for low- and middle-income countries has revealed that just five companies are responsible for almost two-thirds of projects....
Strong spending seen in US medical and health R&D over five year period europeanpharmaceuticalreview
November 22, 2018
The pharmaceutical industry accounted for 67 percent of the total spending on research and development, with federal government accounting for 22 percent…
Evolving World of Pharma: Changing face of the global pharma market: Market Analysis Sarah Harding
October 10, 2018
As well as driving scientific progress through research and development (R&D), and advancing new therapies that improve the health and quality of life of millions of patients around the world, the pharmaceutical industry is a key asset of the global econo

Previous page 1 2 3 4 5 6 7 Next page